A significantly lower expression of ACKR4 was displayed in PH mice and we speculated that the downregulation of ACKR4 may facilitate the progression of PAH, which might be an effective target for PAH prevention, surveillance and therapy. This evidence concerns the gene ACKR4 and pulmonary arterial hypertension.